The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.
Oldenburg RA, Kroeze-Jansema K, Kraan J, Morreau H, Klijn JG, Hoogerbrugge N, Ligtenberg MJ, van Asperen CJ, Vasen HF, Meijers C, Meijers-Heijboer H, de Bock TH, Cornelisse CJ, Devilee P.
Oldenburg RA, et al. Among authors: hoogerbrugge n.
Cancer Res. 2003 Dec 1;63(23):8153-7.
Cancer Res. 2003.
PMID: 14678969